State Street’s Dare Bioscience DARE Stock Holding History
Bought
Maintained
Sold
Other funds holding DARE
VCM
VFT
XT
State Street's DARE Position: Q1 2026 in Review
State Street held its Dare Bioscience (DARE) position steady in Q1 2026 at 23,515 shares worth $42.8K. The position accounts for ﹤0.01% of the portfolio, ranked #4148.
State Street first reported a position in DARE in Q1 2017 and has held it in 22 quarters since. The position peaked at $323K in Q4 2021. 25 funds tracked by Wall St. Rank hold DARE as of Q1 2026.
- State Street held 23,515 shares of Dare Bioscience worth $42.8K as of Q1 2026.
- State Street left its Dare Bioscience share count unchanged in Q1 2026.
- Dare Bioscience made up ﹤0.01% of State Street's portfolio in Q1 2026, its #4148 holding.
- State Street first reported a position in Dare Bioscience in Q1 2017 and has held it in 22 quarters since.
- State Street's Dare Bioscience position peaked at $323K in Q4 2021.
- 25 funds tracked by Wall St. Rank held Dare Bioscience as of Q1 2026.
Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.